The new technology delivers results in as little as 30 hours and reduces hands-on time by up to 40 percent, according to the company's data.

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Thermo Fisher (TMO) lifts 2025 outlook with strong sales and margin gains. Fair value estimate near $570 provides a limited ...

Thermo Fisher Scientific raised its annual profit and revenue forecasts on Wednesday, as the medical equipment maker expects ...

Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump ...

Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its ...

Thermo Fisher Scientific Inc (NYSE: TMO) reported better-than-expected earnings for the third quarter on Wednesday.

Q3 2025 Earnings Call Transcript October 22, 2025 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...

Thermo Fisher (TMO) stock gains as the company beats Street forecasts with its Q3 2025 earnings results thanks to all-around ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 CY2025 results , with sales up 4.9% year on year to $11.12 billion ...

This valuable study investigates the role of HIF1a signaling in epicardial activation and neonatal heart regeneration in mice. Using a combination of genetic and pharmacological approaches, the ...

The automated liquid handling systems market presents growth opportunities driven by biopharmaceutical advancements, with ...